Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and ...

The long-term prospects for these stocks look especially bright.

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

Discover why CLLS is a top speculative Buy, with promising CAR-T therapies, strong big pharma partnerships, and attractive ...

Discover how golden apple snails' eye regeneration offers insights into restoring human vision through genetic understanding and CRISPR technology.

A celebration of radical scientific progress, innovative surgeons and doctors, and gritty patients.

The European Council and Parliament have reached an agreement on the European Commission’s proposal to deregulate new GMOs.

Leading synthetic biologists have shared hard-won lessons from their decade-long quest to build the world's first synthetic ...

Navdanya International has released the report Seeds of Resistance, which documents the global spread of both old and new GMOs and the dismantling of ...

Six new members and three promoted vice-presidents are set to join the European Research Council (ERC) scientific council at ...

The pace of innovation in the Life Sciences field is accelerating, and the regulatory oversight of the resulting products and ...

A phase 1/2 clinical trial examining the CRISPR-engineered allogeneic chimeric antigen receptor (CAR)-T candidate AVC-203 (QUADvance) has been approved by the FDA and the European Medicines Agency ...